SEARCH

SEARCH BY CITATION

References

  • 1
    Frimberger E, Kühner W, Ottenjann R. Operative Laparoskopie-neue Mö-glichkeiten und Perspektiven. Münch Med Wochenschr 1979; 121: 957958.
  • 2
    Frimberger E, Zillinger C, Classen M. Evaluation of laparoscopic cholecys-totomy in the treatment of gallbladder stones. Endoscopy 1992; 24: 717720.
  • 3
    Lanzini A, Jazrawi RP, Kupfer RM, Maudgal DP, Joseph AEA, Northfield TC. Gallstone recurrence after medical dissolution. An overestimated threat? J Hepatol 1986; 3: 241246.
  • 4
    O'Donnel LDJ, Heaton KW. Recurrence and re-recurrence of gallstones after medical dissolution: a long term follow up. Gut 1988; 29: 655658.
  • 5
    Villanova N, Bazzoli F, Frabboni R, Mazella G, Festi D, Barbara L, Roda E. Gallstone recurrence after successful oral bile acid treatment. A 12-year follow-up study and evaluation of long-term postdissolution treatment. Gastroenterology 1989; 97: 726731.
  • 6
    Sackmann M, Ippisch E, Sauerbruch T, Holl J, Brendel W, Paumgartner G. Early gallstone recurrence rate after successful shock-wave therapy. Gastroenterology 1990; 98: 392396.
  • 7
    Schneider HT, Benninger J, Rabes U, Madani N, May A, Hahn EG, Ell C. Recurrent gallstone formation after successful extracorporeal shock-wave lithotripsy. Am J Gastroenterol 1993; 88: 13991404.
  • 8
    Sackmann M, Niller H, Klueppelberg U, von Ritter C, Pauletzki P, Holl J, Berr F, et al. Gallstone recurrence after shock-wave therapy. Gastroenterology 1994; 106: 225230.
  • 9
    Pauletzki J, Althaus R, Holl J, Sackmann M, Paumgartner G. Gallbladder emptying is a determinant of gallstone recurrence after lithotripsy. Gastroenterology 1995; 108: 432A.
  • 10
    Dodds WJ, Groh WJ, Darweesh RMA, Lawson TL, Kishk SMA, Kern MK. Sonographic measurement of gallbladder volume. AJR 1985; 145: 10091011.
  • 11
    Tera H. Stratification of human gallbladder bile in vivo. Acta Chir Scand 1960; 256 (suppl): 485.
  • 12
    Smallwood RA, Jablonski P, McWatts K Intermittent secretion of abnormal bile in patients with cholesterol gallstones. Br Med J 1972; 4: 263266.
  • 13
    Holan KR, Holzbach RT, Hermann RE, Cooperman AM, Claffey WY. Nucleation time: a key factor in the pathogenesis of cholesterol gallstone disease. Gastroenterology 1979; 77: 611617.
  • 14
    Abell LL, Levy BB, Brodie BB, Kendall FE. A simplified method for the estimation of total cholesterol in serum and demonstration of its specificity. J Biol Chem 1952; 195: 357366.
  • 15
    Fiske CH, Subbarow Y. The colorimetric determination of phosphorus. J Biol Chem 1925; 66: 375400.
  • 16
    Talalay P. Enzymatic analysis of steroid hormones. Biochem Anal 1960; 8: 119143.
  • 17
    Carey MC. Critical tables for calculating the cholesterol saturation of native bile. J Lipid Res 1978; 19: 945955.
  • 18
    Methods of enzymatic analysis. In: BergermeyerH, ed. Metabolites 3: Lipids, Amino Acids and Related Compounds. Ed. 3. Vol. 3. Weinheim: VCH Verlagsgesellschaft mbH, 1985.
  • 19
    Pearson JP, Kaura R, Taylor W, Allen A. The composition and polymeric structure of mucus glycoprotein from human gallbladder bile. Biochim Biophys Acta 1982; 706: 221228.
  • 20
    Miquel JF, Groen AK, van Wijland MJA, del Pozo R, Eder MI, von Ritter C. Quantification of mucin in human gallbladder bile: a fast, specific, and reproducible method. J Lipid Res 1995; 36: 2450s2458.
  • 21
    Jüngst D, Lang T, von Ritter C, Paumgartner G. Role of high total protein in gallbladder bile in the formation of cholesterol gallstones. Gastroenterology 1991; 100: 1724s1729.
  • 22
    Stellaard F, Sackmann M, Sauerbruch T, Paumgartner G. Simultaneous determination of cholic acid and chenodeoxycholic acid pool sizes and fractional turnover rates in human serum using 13-C-labeled bile acids. J Lipid Res 1984; 25: 13131319.
  • 23
    Snedecor GW, Cochran WG. Statistical methods. 6th ed. Ames, Iowa University Press; 1974.
  • 24
    Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc 1958; 53: 457s481.
  • 25
    Paumgartner G, Carr-Locke DL, Dubois F, Roda E, Thistle JL. Strategies in the treatment of gallstone disease. Gastroenterology Int 1993; 6: 65s75.
  • 26
    Sauerbruch T, Delius M, Paumgartner G, Holl J, Wess O, Weber W, Hepp W, et al. Fragmentation of gallstones by extracorporeal shock-waves. N Engl J Med 1986; 314: 818822.
  • 27
    Thistle JL, May GR, Bender CE, Williams HJ, LeRoy AD, Nelson PE, Peine CJ, et al. Dissolution of cholesterol gallbladder stones by methyl tert-butylether administered by percutaneous transhepatic catheter. N Engl J Med 1989; 320: 633639.
  • 28
    Leuschner U, Hellstern A, Schmidt K, Fischer H, Güldütuna S, Hübner K, Leuschner M. Gallstone dissolution with Methyl tert-Butyl Ether in 120 patients–Efficacy and safety. Dig Dis Sci 1991; 36: 193199.
  • 29
    Picus D, Hicks ME, Darcy MD, Vesely TM, Kleinhoffer MA, Aliperti G, Edmundowicz SA. Percutaneous cholecystolithotomy: analysis of results and complications in 58 consecutive patients. Radiology 1992; 183: 779784.
  • 30
    The Southern Surgeons Club. A prospective analysis of 1518 laparoscopic cholecystectomies. N Engl J Med 1991; 324: 10731078.
  • 31
    Ruppin DC, Dowling RH. Is recurrence inevitable after gallstone dissolution by bile acid treatment? Lancet 1982; 1: 181185.
  • 32
    Toulet J, Rousselet J, Viteau JM, Duchon Y, Pagniez R, Samain B, Vienne JL. Récidives et prévention des récidives après dissolution de la lithiase vésiculaire par l'acide chénodesoxycholique chez 22 patients. Gastroenterol Clin Biol 1983; 7: 605609.
  • 33
    Hood KA, Gleeson D, Ruppin DC, Dowling RH, and the British Belgian Gall Stone Study Group. Gallstone recurrence and its prevention: the British/Belgian gall stone study group's post dissolution trial. Gut 1993; 34: 12771288.
  • 34
    Jüngst D, Lang T, von Ritter C, Pratschke E, Paumgartner G. Cholesterol nucleation time in gallbladder bile of patients with solitary or multiple cholesterol gallstones. Hepatology 1992; 15: 611617.
  • 35
    Norrby S, Schönebeck J. Long term results with cholecystolithotomy. Acta Chir Scand 1970; 136: 711713.
  • 36
    Donald JJ, Cheslyn-Curtis S, Gillams AR, Russel RCG, Lees WR. Percutaneous cholecystolithotomy: is gall stone recurrence inevitable? Gut 1994; 35: 692695.
  • 37
    Admirand WH, Small DM. The physicochemical basis of cholesterol gallstone formation in man. J Clin Invest 1968; 47: 10431052.
  • 38
    Carey MC, Small DM. The physical chemistry of cholesterol solubility in bile. J Clin Invest 1978; 61: 9981026.
  • 39
    Sedaghat A, Grundy SM. Cholesterol crystals and the formation of cholesterol gallstones. N Engl J Med 1980; 302: 12741277.
  • 40
    Pomeranz I, Shaffer E. Abnormal gallbladder emptying in a subgroup of patients with gallstones. Gastroenterology 1985; 88: 787791.
  • 41
    Hussaini SH, Pereira SP, Murphy GM, Dowling RH. Deoxycholic acid influences cholesterol solubilization and microcrystal nucleation time in gallbladder bile. Hepatology 1995; 22: 17351744.
  • 42
    Jüngst D, Brenner G, Pratschke E, Paumgartner G. Low-dose ursodeoxycholic acid prolongs cholesterol nucleation time in gallbladder bile of patients with cholesterol gallstones. J Hepatol 1989; 8: 16.
  • 43
    Tazuma S, Sasaki H, Mizuno S, Sagawa H, Hashiba S, Horiuchi I, Kajiyama G. Effect of ursodeoxycholic acid administration on nucleation time in human gallbladder bile. Gastroenterology 1989; 97: 173178.
  • 44
    Mizuno S, Tazuma S, Kajiyama G. Stabilization of biliary lipid particles by ursodeoxycholic acid. Prolonged nucleation time in human gallbladder bile. Dig Dis Sci 1993; 38: 684693.
  • 45
    Corradini SG, Arancia G, Calcabrini A, Guardia PD, Baiocchi L, Nistri A, Giacomelli L, et al. Lamellar bodies coexist with vesicles and micelles in human gallbladder bile. Ursodeoxycholic acid prevents cholesterol crystal nucleation by increasing biliary lamellae. J Hepatol 1995; 22: 642657.
  • 46
    Sugerman HJ, Brewer WH, Shiftman ML, Brolin RE, Fobi MAL, Linner JH, MacDonald KG, et al. A multicenter, placebo-controlled, randomized, double-blind, prospective trial of prophylactic ursodiol for the prevention of gallstone formation following gastric-bypass-induced rapid weight loss. Am J Surg 1995; 169: 9197.